Shares of Aemetis, Inc (NASDAQ:AMTX – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.02 and traded as low as $1.47. Aemetis shares last traded at $1.50, with a volume of 469,244 shares traded.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on AMTX shares. Ascendiant Capital Markets reduced their price target on shares of Aemetis from $21.00 to $20.00 and set a “buy” rating for the company in a research report on Wednesday, November 19th. Weiss Ratings reissued a “sell (e+)” rating on shares of Aemetis in a research note on Wednesday, January 21st. Three research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $17.00.
View Our Latest Report on Aemetis
Aemetis Stock Down 2.0%
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in AMTX. Marshall Wace LLP increased its stake in Aemetis by 289.3% during the 4th quarter. Marshall Wace LLP now owns 559,754 shares of the specialty chemicals company’s stock worth $778,000 after buying an additional 415,978 shares during the period. Vanguard Group Inc. raised its stake in shares of Aemetis by 15.3% in the third quarter. Vanguard Group Inc. now owns 2,479,163 shares of the specialty chemicals company’s stock valued at $5,578,000 after acquiring an additional 329,760 shares in the last quarter. Jane Street Group LLC purchased a new stake in shares of Aemetis in the 2nd quarter valued at approximately $634,000. CIBC Bancorp USA Inc. acquired a new stake in shares of Aemetis in the 3rd quarter valued at $563,000. Finally, 683 Capital Management LLC purchased a new stake in shares of Aemetis during the 4th quarter worth $327,000. Institutional investors and hedge funds own 27.02% of the company’s stock.
About Aemetis
Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.
Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.
Featured Articles
- Five stocks we like better than Aemetis
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.
